Henna (Hn, CG7399) encodes the Drosophila phenylalanine hydroxylase, a non-heme-iron, tetrahydrobiopterin-dependent aromatic amino acid hydroxylase of the PANTHER PTHR11473:SF24 (phenylalanine-4-hydroxylase) subfamily that converts L-phenylalanine to L-tyrosine. The full-length 452-residue enzyme (Hn-PA/PC, UniProt P17276) has an N-terminal ACT regulatory domain, a central catalytic domain and a C-terminal oligomerization region, and is expressed in the larval fat body, adult head and a subset of neurons; loss of Henna gives the henna eye-colour phenotype and makes dietary tyrosine conditionally essential. This entry (E8NH57) is the alternative Hn-PD product, a 178-residue polypeptide encoded by transcript Hn-RD that initiates at internal Met275 of the full-length protein and is identical to its residues 275-452. Hn-PD lacks the ACT domain and roughly half of the catalytic domain, including the regions that correspond to the substrate-responsive loop, the pterin-binding loop and the pterin-stacking phenylalanine of human PAH, while keeping the three iron-ligand residues and the C-terminal oligomerization region. It is therefore not expected to carry out the hydroxylation reaction itself; whether the Hn-PD polypeptide accumulates in vivo, binds iron, or associates with full-length Henna subunits is unknown.
Summary: Catalytic activity of full-length Henna transferred by signature to the truncated Hn-PD isoform, which lacks the pterin-binding and substrate-loop half of the catalytic domain.
Reason: The term is correct for the Henna gene (full-length P17276, experimentally shown to hydroxylate phenylalanine and placed by PAINT under PTN000895564 with Hn among the donors), but this IEA is attached to the Hn-PD product E8NH57, which starts at internal Met275 and is identical to P17276 275-452. Mapping human PAH structural sites through a full-length Hn positive control shows that the substrate-responsive loop 131-155, pterin-binding loop 245-250 and cofactor-stacking Phe254 correspond to intact full-length Hn regions (130-154, 244-249, Phe253) but are entirely absent from PD; only 149 of 307 catalytic-domain positions remain. Mutagenesis establishes that the pterin-positioning residues are needed for catalysis. The InterPro/ARBA signatures fire on the retained C-terminal half and the iron ligands, which cannot by themselves form a reaction centre. This is a domain-architecture mismatch, so the catalytic activity should not be asserted for this polypeptide. It says nothing against full-length Henna activity.
Supporting Evidence:
file:DROME/Hn/Hn-bioinformatics/RESULTS.md
The human substrate-responsive loop 131β155 (PMID:12126628), pterin-binding loop 245β250 and cofactor-stacking Phe254 (PMID:10694386) are absent in PD.
Site-specific mutations of Glu286 (E286A and E286Q), Phe254 (F254A and F254L), and Tyr325 (Y325F) have confirmed the important contribution of Glu286 and Phe254 to the normal positioning of the pterin cofactor and catalytic activity of hPheOH.
Summary: Catalytic activity of full-length Henna transferred by signature to the truncated Hn-PD isoform, which lacks the pterin-binding and substrate-loop half of the catalytic domain.
Reason: The term is correct for the Henna gene (full-length P17276, experimentally shown to hydroxylate phenylalanine and placed by PAINT under PTN000895564 with Hn among the donors), but this IEA is attached to the Hn-PD product E8NH57, which starts at internal Met275 and is identical to P17276 275-452. Mapping human PAH structural sites through a full-length Hn positive control shows that the substrate-responsive loop 131-155, pterin-binding loop 245-250 and cofactor-stacking Phe254 correspond to intact full-length Hn regions (130-154, 244-249, Phe253) but are entirely absent from PD; only 149 of 307 catalytic-domain positions remain. Mutagenesis establishes that the pterin-positioning residues are needed for catalysis. The InterPro/ARBA signatures fire on the retained C-terminal half and the iron ligands, which cannot by themselves form a reaction centre. This is a domain-architecture mismatch, so the catalytic activity should not be asserted for this polypeptide. It says nothing against full-length Henna activity.
Supporting Evidence:
file:DROME/Hn/Hn-bioinformatics/RESULTS.md
The human substrate-responsive loop 131β155 (PMID:12126628), pterin-binding loop 245β250 and cofactor-stacking Phe254 (PMID:10694386) are absent in PD.
Site-specific mutations of Glu286 (E286A and E286Q), Phe254 (F254A and F254L), and Tyr325 (Y325F) have confirmed the important contribution of Glu286 and Phe254 to the normal positioning of the pterin cofactor and catalytic activity of hPheOH.
Summary: All three iron-coordinating residue identities are retained, but metal binding requires their correct spatial assembly in a folded pocket.
Reason: All three iron-coordinating residue identities are retained, but metal binding requires their correct spatial assembly in a folded pocket. The large catalytic-domain truncation prevents establishing that geometry from sequence matches alone. In full-length PAH the iron sits in a pocket built by the catalytic domain as a whole, half of which is missing from PD. Iron binding is plausible but neither predicted with confidence nor tested for the native Hn-PD polypeptide.
Supporting Evidence:
file:DROME/Hn/Hn-bioinformatics/RESULTS.md
Iron-ligand positions His284, His289 and Glu329 map to target His10, His15 and Glu55.
The human substrate-responsive loop 131β155 (PMID:12126628), pterin-binding loop 245β250 and cofactor-stacking Phe254 (PMID:10694386) are absent in PD.
Site-specific mutations of Glu286 (E286A and E286Q), Phe254 (F254A and F254L), and Tyr325 (Y325F) have confirmed the important contribution of Glu286 and Phe254 to the normal positioning of the pterin cofactor and catalytic activity of hPheOH.
Summary: True of the Henna gene through its full-length enzyme, but over-attributed to the truncated Hn-PD product, which cannot catalyse the hydroxylation step.
Reason: Phenylalanine hydroxylation by full-length Henna supplies tyrosine and feeds aromatic amino acid metabolism, and this is well supported at the gene level (PAINT PTN000895564 IBD for L-tyrosine biosynthesis and L-phenylalanine catabolism with FlyBase Hn as donor). The row here, however, is on E8NH57 (Hn-PD) and rests only on the electronic catalytic inference (GO_REF:0000108 from GO:0004505, or InterPro signatures). Hn-PD lacks the substrate and pterin architecture needed for catalysis, so it does none of the work of the process by catalysis. A non-catalytic contribution (e.g. association with full-length subunits through the retained C-terminal oligomerization region) is conceivable but has never been tested, so participation is not supported for this product. The claim is not false for the gene, hence over-annotation rather than removal.
Supporting Evidence:
file:DROME/Hn/Hn-bioinformatics/RESULTS.md
Iron-ligand positions His284, His289 and Glu329 map to target His10, His15 and Glu55.
The human substrate-responsive loop 131β155 (PMID:12126628), pterin-binding loop 245β250 and cofactor-stacking Phe254 (PMID:10694386) are absent in PD.
Site-specific mutations of Glu286 (E286A and E286Q), Phe254 (F254A and F254L), and Tyr325 (Y325F) have confirmed the important contribution of Glu286 and Phe254 to the normal positioning of the pterin cofactor and catalytic activity of hPheOH.
Summary: True of the Henna gene through its full-length enzyme, but over-attributed to the truncated Hn-PD product, which cannot catalyse the hydroxylation step.
Reason: Phenylalanine hydroxylation by full-length Henna supplies tyrosine and feeds aromatic amino acid metabolism, and this is well supported at the gene level (PAINT PTN000895564 IBD for L-tyrosine biosynthesis and L-phenylalanine catabolism with FlyBase Hn as donor). The row here, however, is on E8NH57 (Hn-PD) and rests only on the electronic catalytic inference (GO_REF:0000108 from GO:0004505, or InterPro signatures). Hn-PD lacks the substrate and pterin architecture needed for catalysis, so it does none of the work of the process by catalysis. A non-catalytic contribution (e.g. association with full-length subunits through the retained C-terminal oligomerization region) is conceivable but has never been tested, so participation is not supported for this product. The claim is not false for the gene, hence over-annotation rather than removal.
Supporting Evidence:
file:DROME/Hn/Hn-bioinformatics/RESULTS.md
Iron-ligand positions His284, His289 and Glu329 map to target His10, His15 and Glu55.
The human substrate-responsive loop 131β155 (PMID:12126628), pterin-binding loop 245β250 and cofactor-stacking Phe254 (PMID:10694386) are absent in PD.
Site-specific mutations of Glu286 (E286A and E286Q), Phe254 (F254A and F254L), and Tyr325 (Y325F) have confirmed the important contribution of Glu286 and Phe254 to the normal positioning of the pterin cofactor and catalytic activity of hPheOH.
GO:0016714 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen
IEA GO_REF:0000002
REMOVE
Summary: Catalytic activity of full-length Henna transferred by signature to the truncated Hn-PD isoform, which lacks the pterin-binding and substrate-loop half of the catalytic domain.
Reason: The term is correct for the Henna gene (full-length P17276, experimentally shown to hydroxylate phenylalanine and placed by PAINT under PTN000895564 with Hn among the donors), but this IEA is attached to the Hn-PD product E8NH57, which starts at internal Met275 and is identical to P17276 275-452. Mapping human PAH structural sites through a full-length Hn positive control shows that the substrate-responsive loop 131-155, pterin-binding loop 245-250 and cofactor-stacking Phe254 correspond to intact full-length Hn regions (130-154, 244-249, Phe253) but are entirely absent from PD; only 149 of 307 catalytic-domain positions remain. Mutagenesis establishes that the pterin-positioning residues are needed for catalysis. The InterPro/ARBA signatures fire on the retained C-terminal half and the iron ligands, which cannot by themselves form a reaction centre. This is a domain-architecture mismatch, so the catalytic activity should not be asserted for this polypeptide. It says nothing against full-length Henna activity.
Supporting Evidence:
file:DROME/Hn/Hn-bioinformatics/RESULTS.md
The human substrate-responsive loop 131β155 (PMID:12126628), pterin-binding loop 245β250 and cofactor-stacking Phe254 (PMID:10694386) are absent in PD.
Site-specific mutations of Glu286 (E286A and E286Q), Phe254 (F254A and F254L), and Tyr325 (Y325F) have confirmed the important contribution of Glu286 and Phe254 to the normal positioning of the pterin cofactor and catalytic activity of hPheOH.
Q: Is the Hn-PD polypeptide (E8NH57, initiating at internal Met275) translated and stable in vivo, and in which tissues or stages is the Hn-RD transcript expressed relative to Hn-RA/RC?
Q: Can Hn-PD bind iron or co-assemble with full-length Henna subunits through the retained C-terminal oligomerization region, and if so does it modulate phenylalanine hydroxylase activity?
Suggested Experiments
Experiment: Detect endogenous Hn-PD with a C-terminal epitope tag knocked into the Hn locus or by targeted proteomics of peptides unique to its N-terminus, comparing tissues where Hn-RD is expressed.
Experiment: Co-express tagged Hn-PD with full-length Hn in S2 cells, test co-immunoprecipitation and measure phenylalanine hydroxylase activity of the mixed population versus full-length Hn alone.
External Prediction Reviews
These computational predictions are reviewed separately from the GOA annotation set used for this review. The assessments below are from this project and do not constitute official GO annotations or endorsement by GO/UniProt. They are not included in the existing annotation review above.
The native Hn-PD product lacks conserved substrate/cofactor architecture required for pteridine-dependent hydroxylase activity, so the activity prediction is refuted for this product. Participation in aromatic amino acid metabolism by a non-catalytic route is neither shown nor excluded, so the process prediction is uncertain.
Review rationale: Full-length Henna (P17276) participates in aromatic amino acid metabolism by catalysing phenylalanine 4-hydroxylation. Hn-PD (178 residues, identical to P17276 275-452, initiating at internal Met275) lacks the ACT domain and the regions corresponding to the human PAH substrate-responsive loop 131-155, pterin-binding loop 245-250 and cofactor-stacking Phe254; only 149 of 307 catalytic-domain positions remain, although the iron ligands are retained. PD is therefore unlikely to perform the hydroxylation step itself. That does not refute participation in the process. PD retains the C-terminal part of the Henna sequence, the native product has not been assayed, and a non-catalytic contribution, such as association with or modulation of full-length Henna, is neither shown nor excluded. The missing catalytic architecture accounts for the catalytic route only, and there is no positive evidence against involvement, so the call is uncertain. Novelty is not at issue, as the term is an existing electronic annotation on E8NH57.
file:DROME/Hn/Hn-bioinformatics/RESULTS.md: "The human substrate-responsive loop 131β155 (PMID:12126628), pterin-binding loop 245β250 and cofactor-stacking Phe254 (PMID:10694386) are absent in PD."
GO:0016714 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygenGO_MF
Review rationale: The exact native PD isoform lacks the PAH substrate-responsive loop, pterin-binding loop and cofactor-stacking Phe site, established by human-to-full-length-Hn mapping and their absence from PD. Primary structural and mutagenesis studies identify these as reaction-center features; only 149 of 307 aligned catalytic-domain residues remain. The three iron ligands and Glu cofactor contact are retained, but cannot supply the missing substrate/cofactor architecture. This refutes transfer of conventional pteridine-dependent hydroxylase chemistry, despite overlap with an existing electronic annotation. The conclusion concerns intrinsic catalysis, not all possible process participation or a supposed error in the native transcript sequence.
Supporting Evidence:
file:DROME/Hn/Hn-bioinformatics/RESULTS.md: "The human substrate-responsive loop 131β155 (PMID:12126628), pterin-binding loop 245β250 and cofactor-stacking Phe254 (PMID:10694386) are absent in PD."
PMID:10694386: "Site-specific mutations of Glu286 (E286A and E286Q), Phe254 (F254A and F254L), and Tyr325 (Y325F) have confirmed the important contribution of Glu286 and Phe254 to the normal positioning of the pterin cofactor and catalytic activity of hPheOH."
PMID:12126628: "The largest change occurs in the loop region comprising residues 131-155"
Henna (Hn) encodes a tryptophan phenylalanine hydroxylase. It is a dual function enzyme: it hydroxylates both phenylalanine to generate tyrosine, as well as tryptophan to generate the precursor for peripheral (non-neuronal) serotonin. It is also involved in pteridine synthesis.